Cervical cancer is the second most prevalent cancer among women, and it arises from cells
that originate in the cervix uteri. Among several causes of cervical malignancies, infection …

Background The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …

Introduction: The 9-valent human papillomavirus (9vHPV) vaccine covers the same HPV
types (6/11/16/18) as the quadrivalent HPV (qHPV) vaccine and 5 additional cancer-causing …

Background The long-term effectiveness of the quadrivalent human papillomavirus (qHPV)
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …

Vaccination against the human papillomavirus (HPV) is an effective primary prevention
measure for HPV-related diseases. For children and young adolescents, the uptake of the …

OBJECTIVES: We describe the final 10-year data for the long-term follow-up study of the 4-
valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents …

Despite a high prevalence of oncogenic human papilloma virus (HPV) infection and cervical
cancer mortality, HPV vaccination is not currently available in Mali. Knowledge of HPV and …

Cervical cancer is a malignant neoplasm arising from cells that originate in the cervix uteri. It
is the second most prevalent cancer among women. It can have several causes; an infection …

This study assessed HPV vaccination and its correlates among culturally diverse 18–26 year-
old community college women in Los Angeles. Specific research questions were:(1) What …

As the current COVID-19 pandemic illustrates, vaccination is the most powerful method of
disease prevention and public confidence in vaccines depends on their safety and efficacy …